Pages that link to "Q28731691"
Jump to navigation
Jump to search
The following pages link to CNTF and retina (Q28731691):
Displaying 50 items.
- Neuroprotection in Glaucoma (Q26740388) (← links)
- Update on Clinical Trials in Dry Age-related Macular Degeneration (Q26767098) (← links)
- Neuroinflammatory responses in diabetic retinopathy (Q26798351) (← links)
- Emerging gene therapies for retinal degenerations (Q26853366) (← links)
- Review: the history and role of naturally occurring mouse models with Pde6b mutations (Q28304672) (← links)
- Safety and Proof-of-Concept Study of Oral QLT091001 in Retinitis Pigmentosa Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) (Q28551677) (← links)
- Spontaneous Regeneration of Human Photoreceptor Outer Segments (Q30659006) (← links)
- Mesenchymal stem cells attenuate hydrogen peroxide-induced oxidative stress and enhance neuroprotective effects in retinal ganglion cells (Q32186021) (← links)
- Ciliary neurotrophic factor and fibroblast growth factor increase the speed and number of regenerating axons after optic nerve injury in adult Rana pipiens (Q34053317) (← links)
- A highly efficient catalyst for oxime ligation and hydrazone-oxime exchange suitable for bioconjugation (Q34165587) (← links)
- A prospective longitudinal study of retinal structure and function in achromatopsia. (Q34166706) (← links)
- CNGB3-achromatopsia clinical trial with CNTF: diminished rod pathway responses with no evidence of improvement in cone function (Q34312144) (← links)
- Dark-adaptation functions in molecularly confirmed achromatopsia and the implications for assessment in retinal therapy trials. (Q34323173) (← links)
- Dry age-related macular degeneration: A currently unmet clinical need (Q34378033) (← links)
- Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial (Q34454997) (← links)
- A novel in vivo model of focal light emitting diode-induced cone-photoreceptor phototoxicity: neuroprotection afforded by brimonidine, BDNF, PEDF or bFGF. (Q34612126) (← links)
- Glaucoma management: relative value and place in therapy of available drug treatments (Q35079342) (← links)
- A new immunodeficient pigmented retinal degenerate rat strain to study transplantation of human cells without immunosuppression (Q35220260) (← links)
- Protection of pattern electroretinogram and retinal ganglion cells by oncostatin M after optic nerve injury (Q35268594) (← links)
- Spectral-domain optical coherence tomography staging and autofluorescence imaging in achromatopsia. (Q35581056) (← links)
- Sustained Neural Stem Cell-Based Intraocular Delivery of CNTF Attenuates Photoreceptor Loss in the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis (Q35636176) (← links)
- CNTF Gene Therapy Confers Lifelong Neuroprotection in a Mouse Model of Human Retinitis Pigmentosa (Q35964344) (← links)
- Treatment Modalities for Idiopathic Macular Telangiectasia: An Evidence-Based Systematic Review of the Literature (Q35989542) (← links)
- Reprogramming of adult rod photoreceptors prevents retinal degeneration (Q36583066) (← links)
- Inhibition of mTOR signaling protects photoreceptor cells against serum deprivation by reducing oxidative stress and inducing G2/M cell cycle arrest (Q36817429) (← links)
- Dendritic cell dysfunction and diabetic sensory neuropathy in the cornea (Q36867273) (← links)
- Ciliary Neurotrophic Factor Promotes the Migration of Corneal Epithelial Stem/progenitor Cells by Up-regulation of MMPs through the Phosphorylation of Akt (Q36897634) (← links)
- Transient photoreceptor deconstruction by CNTF enhances rAAV-mediated cone functional rescue in late stage CNGB3-achromatopsia (Q36915103) (← links)
- CNTF Attenuates Vasoproliferative Changes Through Upregulation of SOCS3 in a Mouse-Model of Oxygen-Induced Retinopathy (Q37179640) (← links)
- CNTF-mediated protection of photoreceptors requires initial activation of the cytokine receptor gp130 in Müller glial cells (Q37340676) (← links)
- Jak/Stat signaling regulates the proliferation and neurogenic potential of Müller glia-derived progenitor cells in the avian retina (Q37349009) (← links)
- Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice (Q37707929) (← links)
- Cell replacement and visual restoration by retinal sheet transplants (Q38024553) (← links)
- Non-syndromic retinal ciliopathies: translating gene discovery into therapy (Q38030482) (← links)
- Gene therapy in animal models of autosomal dominant retinitis pigmentosa (Q38053151) (← links)
- Autocrine and paracrine interactions and neuroprotection in glaucoma (Q38077464) (← links)
- Neurotrophic molecules in the treatment of neurodegenerative disease with focus on the retina: status and perspectives (Q38086746) (← links)
- The potential of stem cell research for the treatment of neuronal damage in glaucoma. (Q38109499) (← links)
- The role of Müller glia and microglia in glaucoma (Q38115460) (← links)
- A perspective on the role of the extracellular matrix in progressive retinal degenerative disorders (Q38171998) (← links)
- Intraperitoneal administration of adipose tissue-derived stem cells for the rescue of retinal degeneration in a mouse model via indigenous CNTF up-regulation by IL-6. (Q38675523) (← links)
- RPGR-associated retinopathy: clinical features, molecular genetics, animal models and therapeutic options. (Q38722345) (← links)
- Caveolins and caveolae in ocular physiology and pathophysiology. (Q38963501) (← links)
- Emerging therapies for inherited retinal degeneration (Q39032340) (← links)
- The promise of stem cell-based therapeutics in ophthalmology. (Q39236145) (← links)
- Persistent inflammatory state after photoreceptor loss in an animal model of retinal degeneration. (Q41084355) (← links)
- The cone dysfunction syndromes (Q41225313) (← links)
- The inositol metabolism pathway as a target for neuroprotective strategies (Q41779887) (← links)
- Simultaneous dual protein labeling using a triorthogonal reagent (Q41930524) (← links)
- Emerging Treatments for Retinitis Pigmentosa: Genes and stem cells, as well as new electronic and medical therapies, are gaining ground (Q42058183) (← links)